M
MED
The startup develops bioidentical therapeutics aimed at reeducating dysregulated immune systems to facilitate functional tissue recovery. Their expertise spans therapeutic areas including infectious diseases and metabolic disorders, enabling clients to effectively manage inflammatory diseases and syndromes.
Traction 6/10Founded 20171.4K
Besançon, France · HQ
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$750KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops bioidentical therapeutics aimed at reeducating dysregulated immune systems to facilitate functional tissue recovery. Their expertise spans therapeutic areas including infectious diseases and metabolic disorders, enabling clients to effectively manage inflammatory diseases and syndromes.